4CPS-088 Effectiveness of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C

Autor: José Manuel Zozaya, M Sarobe, B Larrayoz, Cristina Burgui, Regina Juanbeltz, M Gracia-Ruiz de Alda, Jesús Castilla, R San Miguel

Publikováno v: Section 4: Clinical Pharmacy Services.

Background The availability of new pangenotypic direct-acting antiviral (DAA) combinations has simplified the treatment of chronic hepatitis C. Clinical trials have shown high rates of sustained virological response (SVR), but there is a paucity of d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aa9be7b689c1d81fd95c0a53c3cf9520
https://doi.org/10.1136/ejhpharm-2019-eahpconf.237

DI-046 Analysis of treatment discontinuation by iatrogenesis related to DOLUTEGRAVIR/ABACAVIR/LAMIVUDINE

Autor: R de la Riva Bohigas, M Gracia Ruiz de Alda, M. Rivero Marcotegui, C Fontela Bulnes, A Muñoz San Juan, J Repáraz Padrós, J Polo García, J Preciado Goldaracena, J Alfaro Basarte, R Juanbeltz Zurbano

Publikováno v: Drug information and pharmacotherapy.

Background Dolutegravir/abacavir/lamivudine (Triumeq) is a new oral drug to treat human immunodeficiency virus (HIV) offering a single pill regimen. Treatment discontinuations due to adverse events occurred in our clinical experience raising concerns

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::471e36d2d228b7a7140b36583aa2ca45
https://doi.org/10.1136/ejhpharm-2017-000640.293

Bacteriemia por Shewanella algae en paciente inmunodeprimida tras contacto con agua salada

Autor: M. Gracia-Ruiz de Alda, F. Jover-Díaz, C. Martín-González, J.M. Cuadrado-Pastor

Publikováno v: Revista Clínica Española. 211:489-490

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c1f8a593c103b0d43a309652a108494a
https://doi.org/10.1016/j.rce.2011.02.014

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia.

Autor: Avendaño-Solá C; Clinical Pharmacology Department, Hospital Universitario Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Hospital Puerta de Hierro-Segovia de Arana, SCReN Clinical Trials Platform, Madrid, Spain., Ramos-Martínez A; Infectious Diseases Unit, Department of Internal Medicine and., Muñez-Rubio E; Infectious Diseases Unit, Department of Internal Medicine and., Ruiz-Antorán B; Clinical Pharmacology Department, Hospital Universitario Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Hospital Puerta de Hierro-Segovia de Arana, SCReN Clinical Trials Platform, Madrid, Spain., Malo de Molina R; Respiratory Medicine Service, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Torres F; Clinical Pharmacology Department, Hospital Clinic Barcelona, Barcelona, Spain.; Biostatistics Unit, Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain., Fernández-Cruz A; Infectious Diseases Unit, Department of Internal Medicine and., Calderón-Parra J; Infectious Diseases Unit, Department of Internal Medicine and., Payares-Herrera C; Clinical Pharmacology Department, Hospital Universitario Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Hospital Puerta de Hierro-Segovia de Arana, SCReN Clinical Trials Platform, Madrid, Spain., Díaz de Santiago A; Infectious Diseases Unit, Department of Internal Medicine and., Romera-Martínez I; Department of Hematology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Pintos I; Infectious Diseases Unit, Department of Internal Medicine and., Lora-Tamayo J; Department of Internal Medicine, Instituto de Investigación 'i+12' and., Mancheño-Losa M; Department of Internal Medicine, Instituto de Investigación 'i+12' and., Paciello ML; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain., Martínez-González AL; Department of Internal Medicine, and., Vidán-Estévez J; Department of Hematology, Complejo Asistencial Universitario de León, León, Spain., Nuñez-Orantos MJ; Infectious Diseases Unit, Department of Internal Medicine and., Saez-Serrano MI; Hematology Service, Hospital Universitario Clinico San Carlos, Madrid, Spain., Porras-Leal ML; Infectious Diseases Unit, Department of Internal Medicine, and., Jarilla-Fernández MC; Hematology and Hemotherapy Service, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., Villares P; Department of Internal Medicine, Hospital Universitario HM Sanchinarro, Madrid, Spain., de Oteyza JP; Department of Hematology, Hospital Universitario HM Sanchinarro, Universidad CEU San Pablo Madrid, Spain., Ramos-Garrido A; Blood Transfusion Military Center, Ministry of Defense, Spain., Blanco L; Centro de Hemoterapia y Hemodonación de Castilla y León, Valladolid, Spain., Madrigal-Sánchez ME; Centro de Transfusión de Ciudad Real, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., Rubio-Batllés M; Centro de Transfusión de Albacete y Cuenca, Albacete, Spain., Velasco-Iglesias A; Spanish Clinical Research Network (ISCIII), IIS -Hospital Puerta de Hierro-Segovia de Arana, Madrid, Spain., Paño-Pardo JR; Division of Infectious Diseases and., Moreno-Chulilla JA; Division of Hematology, Hospital Clínico Universitario Zaragoza-IIS Aragón, Zaragoza, Spain., Muñiz-Díaz E; Inmunohematology Division, Banc de Sang i Teixits, Barcelona, Spain., Casas-Flecha I; Respiratory Virus and Influenza Unit and., Pérez-Olmeda M; Laboratorio de Serología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain., García-Pérez J; AIDS Immunopathogenesis Unit, Instituto de Salud Carlos III, Madrid, Spain., Alcamí J; AIDS Immunopathogenesis Unit, Instituto de Salud Carlos III, Madrid, Spain., Bueno JL; Department of Hematology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Duarte RF; Department of Hematology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2021 Oct 15; Vol. 131 (20).